Multi-Organ Fibrosis Modeling Service
Introduction What We Can Offer How We Can Help Why Choose Us Customer Reviews FAQs Related Services Contact Us
Creative Biolabs offers biotechnology and pharmaceutical investigators a human-derived testing environment for high-fidelity therapeutic screening. By co-culturing engineered three-dimensional hepatic, renal, and cardiac microtissues within a PDMS-free cyclic olefin copolymer perfusion circuit, the system preserves systemic organ-organ communication. Real-time biophysical telemetry coupled with unsupervised image-processing algorithms provides robust translational data. This integrated approach de-risks candidate molecules prior to animal testing, maps systemic off-target liabilities early, and streamlines candidate prioritization for preclinical dossier compilation.
Introduction of Multi-Organ Fibrosis Modeling Service
Organ fibrosis is a progressive, systemic pathological process. Emerging peer-reviewed literature in bioengineering and microphysiological systems demonstrates that mechanical forces and systemic multicellular crosstalk coordinate the pathological "fibrogenic niche," driving progressive organ failure. Historically, static 2D cell cultures, pre-activated cell lines, and animal models have failed to replicate this complex human-specific pathophysiology. In conclusion, Creative Biolabs’ Multi-Organ Fibrosis Modeling Service successfully bridges this translational gap by dynamically linking mature, human-derived microtissues under physiological perfusion, providing drug developers with an unprecedented, highly predictive preclinical validation platform.
Request a Consultation
Fig.1 Overview of the etiologies and mechanisms of organ fibrosis. 1
What We Can Offer
Bespoke Co-Culture and Organ Configuration
We design custom microfluidic circuits tailored to your compound's specific pathway. This allows seamless on-demand fluidic linkage of hepatic, renal, cardiac, pulmonary, or intestinal chambers to model systemic target interaction.
Dynamic, Low-Shear Perfusion Control
Our active perfusion systems apply precise physiological fluid forces. This maintains cell polarity, replicates tissue-specific hemodynamics, and prevents the pathological necrotic core formation commonly observed in traditional static three-dimensional cultures.
Proprietary, Reversible Human Cellular Phenotypes
We integrate mature primary cells alongside our proprietary human stellate cell line. This ultra-responsive system allows researchers to study both the active progression of scarring and successful myofibroblast reversion back to quiescent states.
Ultra-Low Adsorption PDMS-Free Technology
Built from medical-grade cyclic olefin copolymers, our chips prevent the non-specific absorption of lipophilic test compounds. This ensures highly stable perfusion concentrations, yielding highly accurate and reproducible dosing metrics.
How Creative Biolabs Can Assist Your Project
Highlights
Advanced Microphysiological Systems
Our vascularly linked human-derived co-cultures represent a major paradigm shift. By modeling physiological flow and organ crosstalk, we overcome the historical translational limitations associated with static 2D assays and animal models.
Reversible Human Stellate Lines
By replacing chronically pre-activated cell models with responsive human LSC-1 stellate cells, our platform enables researchers to study both the active progression and the biological reversion of established tissue scarring.
Adsorption-Free Copolymer Architecture
We construct our microfluidic chips from medical-grade cyclic olefin copolymers rather than traditional silicones. This zero-adsorption design prevents lipophilic compound loss, ensuring accurate potency metrics and reproducible dosing curves.
Automated Machine-Learning Analysis
We eliminate subjective human bias from histopathological scoring. Our standardized image-processing pipeline automatically quantifies structural tissue remodeling, extracellular matrix fiber alignment, and cellular transitions using advanced unsupervised algorithms.
Get a Quote Today to get a detailed project estimate and study design blueprint customized for your drug discovery objectives.
Customer Reviews
-
Cardiovascular Safety Verified
Creative Biolabs’ fluidic heart tissue platform resolved our drug adsorption issues completely. We successfully tracked gap junction rescue and synchronized beating patterns under stress, yielding highly reliable in vivo translational data. - Dr. E**a S.
-
True Stellate Reversion
We finally achieved physiological stellate cell reversion using their responsive LSC-1 model. Modeling transition cycles in 3D without pre-activation artifacts has thoroughly transformed our screening workflow for anti-fibrotic discovery. - Dr. M**a V.
FAQs
How does Creative Biolabs prevent non-specific drug adsorption on the microfluidic platform?
We construct our chips using medical-grade, PDMS-free cyclic olefin copolymers lined with ultra-low-adsorption fluoropolymers. This design prevents lipophilic molecules from sticking to channel walls, ensuring stable perfusion concentrations and highly reproducible preclinical dosing metrics.
Can we evaluate advanced therapeutic modalities, such as CAR-T or monoclonal antibodies?
Yes. Our vascularly linked microfluidic perfusion channels are fully compatible with complex biologics, monoclonal antibodies, and cellular therapies. Introduce active compounds into recirculating flow to analyze target homing, barrier penetration, and cell-specific depletion.
Related Services
Evaluate the phenotypic shifts of human macrophages from inflammatory states to tissue-remodeling states within our microfluidic co-cultures, optimizing the preclinical screening of targeted immunomodulatory drug candidates.
Learn More →
Quantify real-time extracellular matrix deposition and enzyme-driven cleavage dynamics using advanced fluorogenic substrates and bio-orthogonal labeling within engineered microenvironments, facilitating high-resolution structural remodeling analysis.
Learn More →
How to Contact Us
Creative Biolabs directly addresses the persistent translational barriers inherent in traditional anti-fibrotic discovery workflows. By substituting rigid, two-dimensional substrates and poorly translating animal models with vascularly interconnected, PDMS-free cyclic olefin copolymer microfluidic platforms populated by functional human tissues, this platform equips pharmacology and toxicology teams to acquire physiologically relevant datasets with high speed and fidelity.
Our scientific development specialists are prepared to customize a microphysiological panel aligned with your specific experimental objectives, please contact us.
Reference
-
Chen, Xiangqi et al. "Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies." Signal transduction and targeted therapy vol. 11,1 82. 6 Mar. 2026. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.1038/s41392-025-02532-0
